Scott Eggener

9PUBLICATIONS
94CO-AUTHORS
Molecular targetsPredictive and prognostic markersPacific Peoples genomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 20, 2025
Accelerating Drug Development in Hormone-Naïve Prostate Cancer through Multimodal Therapy Strategies: The MetaCURE Phase 2 Randomized Clinical Trial.

Deaglan McHugh, Matthew Dallos, Min Yuen Teo

|Jan 09, 2025
Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline.

Evan Y Yu, R Bryan Rumble, Neeraj Agarwal

|Jul 22, 2024
Stockholm3 in a Multiethnic Cohort for Prostate Cancer Detection (SEPTA): A Prospective Multicentered Trial.

Hari T Vigneswaran, Martin Eklund, Andrea Discacciati

|Jan 23, 2024
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19).

Rahul Aggarwal, Glenn Heller, David W Hillman

|Sep 01, 2023
Risk Factors for Relapse in Nonseminomatous Testicular Cancer After Postchemotherapy Retroperitoneal Lymph Node Dissection With Viable Residual Cancer.

Luca Antonelli, Davide Ardizzone, Isamu Tachibana

|Mar 13, 2023
Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.

Siamak Daneshmand, Clint Cary, Timothy Masterson

Pageof 2

Frequent Collaborators

3 joint publications

Alejandro Berlin

3 joint publications

Andrew Vickers

3 joint publications

Howard Wolinsky

3 joint publications

Matthew R Cooperberg